cellular
• reduced ATP levels (mainly in mitochondria)
• reduced ATP levels in liver
• 40% reduction in NADPH and NADP+ levels
• normal NADP+ to NADPH ratio
|
• accumulation of acylcarnitines and decreased levels of intermediates of TCA cycle
|
homeostasis/metabolism
• accumulation of acylcarnitines and decreased levels of intermediates of TCA cycle
|
• increased levels of folic acid, dihydrofolate and 10-formyl-trihydrofolate
• normal total folate pool
|
• 8.3-fold reduction
|
• 5.2-fold increase in cystine plasma levels
• reduced cysteinylglycine levels
|
• 5.6-fold reduction
|
• strongly reduced coenzyme A (CoA) levels
|
• 8-fold change in reduced/oxidized vitamin C ratio
• 5-fold reduction
• 1.7-fold increase in dehydroascorbate (oxidized vitamin C)
|
• 40% reduction in NADPH and NADP+ levels
• normal NADP+ to NADPH ratio
|
liver/biliary system
N |
• normal liver morphology
|
• increased fat deposits in hepatocytes
|
endocrine/exocrine glands
N |
• normal pancreas morphology and histology
|
growth/size/body
N |
• normal body weight at weaning and age 6 months and normal growth
|
cardiovascular system
N |
• normal heart morphology and histology
|
immune system
N |
• normal spleen morphology and histology
|
behavior/neurological
N |
• normal food intake
|
mortality/aging
N |
• viable
|
nervous system
N |
• normal brain morphology and histology
|
renal/urinary system
N |
• normal kidney morphology and histology
|
reproductive system
N |
• fertile, normal litter size, normal Mendelian inheritance ratio
|
respiratory system
N |
• normal lung morphology and histology
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
metabolic dysfunction-associated steatotic liver disease | DOID:0080208 |
OMIM:613282 OMIM:613387 |
J:299012 |